Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website https://jocmr.elmerjournals.com

Original Article

Volume 16, Number 11, December 2024, pages 536-546


Downregulation of miR-25-3p and Its Impact on PTAFR and IGF2BP3 Expression in Type 2 Diabetes Mellitus: Implications for Biomarker Discovery and Disease Pathogenesis

Figures

Figure 1.
Figure 1. Principal component analysis (PCA) mapping showed the differential miRNA expression between DM and NDM. DM: diabetes mellitus; miRNA: microRNA; NDM: non-diabetes mellitus.
Figure 2.
Figure 2. Hierarchical clustering showed the differential miRNA expression between DM and NDM. DM: diabetes mellitus; miRNA: microRNA; NDM: non-diabetes mellitus.
Figure 3.
Figure 3. RNA secondary structure of miR-25-3p.
Figure 4.
Figure 4. miR-25-3p expression in vein tissue from the human miRNA tissue atlas. miRNA: microRNA.
Figure 5.
Figure 5. miR-25-3p downregulated in DM patients. DM: diabetes mellitus.
Figure 6.
Figure 6. PTAFR and IGF2BP3 upregulated in DM patients. DM: diabetes mellitus; IGF2BP3: insulin-like growth factor 2 mRNA binding protein 3; PTAFR: platelet-activating factor receptor.

Tables

Table 1. Characteristics of Patients With Type 2 Diabetes Mellitus (DM) and Patients Without Type 2 Diabetes Mellitus (NDM)
 
Sample IDSexAge (years)FBS (mg/dL)HbA1c (%)
FBS: fasting blood sugar; HbA1c: hemoglobin A1c.
DM 1M3327013.8
DM 2F7218211.9
DM 3M8320511.7
DM 4F4114611.7
DM 5F4014511.3
DM 6M402099.8
DM 7F621919.8
DM 8F661269.8
DM 9F622119.2
DM 10F491568.6
NDM 11M46954.4
NDM 12F46794.7
NDM 13F33815.3
NDM 14F40845.4
NDM 15F47905.4
NDM 16M43915.4
NDM 17M54825.5
NDM 18M26915.5
NDM 19F59995.5
NDM 20M56805.6

 

Table 2. In-House and Third-Party Resources Are Included in miRTargetLink 2.0 to Select the Potential miRNA Expression Involved in the Pathogenesis of Diabetes
 
DatabaseTaskOwn/third-partyTypeVersion
miRNA: microRNA.
miRTarBasemiRNA target databaseThird-partyDatabase8.0 (2020)
miRDBmiRNA target databaseThird-partyDatabase6.0

 

Table 3. Ten Downregulated and Six Upregulated miRNAs Are Involved in the Pathogenesis of Diabetes
 
No.miRNAGlucose metabolismPlatelet reactivityInsulin resistance
miRNA: microRNA.
Ten downregulated
  1.miR-92a-3pUGP2PTAFRIGF2
INSIG1
  2.miR-140-3p---
  3.let-7b-5pUGCGPTAFRIGF2BP1
IGF1R
IGF2BP3
  4.miR-25-3pUGP2PTAFRIGF2BP3
INSIG1
  5.miR-425-5pSOGA1PAFAH1B1IGF1R
  6.miR-93-5pUGCG
SOGA1
PAFAH1B2
PDGFRB
PAFAH1B1
IGF2BP1
  7.miR-6807-5pSOGA1--
  8.miR-103a-3pSOGA1PAFAH1B2-
  9.miR-24-3pUGCGPAFAH1B2
PDGFRB
INSIG1
  10.miR-210-3p--IGF2
Six upregulated
  1.miR-4428SOGA1--
  2.miR-4253-PAFAH1B2-
  3.miR-150-3p-PDGFRB
PAFAH1B1
-
  4.miR-5100SOGA1--
  5.miR-939-5pSOGA1-IGF2
  6.miR-6824-5p---